Point-of-care glucose testing or also known as bedside glucose testing, is a method of measuring glucose levels in the blood at the point of care, such as in a hospital, clinic, or doctor’s office. The introduction of point-of-care glucose testing has shown significant advantage over the traditional method in terms of immediate results, timely decisions, and cost-efficacy.

Request Sample PDF here @ https://univdatos.com/report/point-of-care-glucose-testing-market/get-a-free-sample-form.php?product_id=36290

The technology behind point-of-care glucose testing has evolved over the years, and now there are several methods available for measuring blood glucose levels. The most common method is the use of glucose meters, which are portable devices that measure glucose levels in a small sample of blood obtained by pricking the patient’s finger with a lancet. Glucose meters have become increasingly sophisticated and can now store and transmit data, making it easier for healthcare providers to monitor a patient’s glucose levels over time. Additionally, some glucose meters are now equipped with advanced features such as the ability to track insulin doses and provide alerts when glucose levels fall outside of a target range.

One of the major factors driving the growth of the point-of-care testing market is the increasing adoption of a sedentary lifestyle and associated increase in the prevalence of diabetes worldwide.  According to the data from World Health Organization, there are over 400 million people with diabetes across the world, and its treatment constitutes around 12% of the total healthcare expenditure on a global scale. It has emerged as a global epidemic and afflicted millions worldwide.

Point-of-care glucose testing has several benefits for patients and healthcare providers. First and foremost, it provides immediate results, allowing for timely adjustments to medication and treatment plans. Additionally, it can reduce the need for frequent blood draws, which can be uncomfortable and inconvenient for patients. Point-of-care glucose testing can also help improve patient outcomes by providing more accurate glucose readings and enabling healthcare providers to make more informed decisions about patient care.

Further, the introduction of artificial intelligence and machine learning will also create opportunities in point-of-care glucose testing. As more tests move out of the core laboratory and are performed by nonlaboratory professionals, AI and ML are being used in point-of-care glucose testing to make cheaper, faster, and easier to check for quality control.

Ask for Customization @ https://univdatos.com/report/point-of-care-glucose-testing-market/get-a-free-sample-form.php?product_id=36290

Furthermore, the surge in the prevalence of lifestyle disorders is also a major factor contributing to the increase in the prevalence of chronic diseases. For instance, as per the data provided by the Global Obesity Observatory (2021), Mexico presents a national risk of obesity development on a scale of 10 to be 8. This represents that the majority of the population in Mexico either falls in the bracket of the obese population or is highly susceptible to being obese in the coming years. Many studies have established that excess body fat increases the risk for diabetes Additionally, the increase in aging population in the country is also said to contribute to diabetes prevalence.     

Counties such as China and Japan in the Asia-Pacific region are also rapidly investing in point-of-care testing research. For example, in 2020       Acon Laboratories launched a new device called the Mission Ultra, which is designed to provide fast and accurate glucose readings for patients with diabetes.      

Figure 1: Price Analysis of Point-of-Care Testing by Region

Get more information , Please Visit us :

https://univdatos.com/report/point-of-care-glucose-testing-market/

Top Investors of the Point-of-Care Testing

Over the last few years, point-of-care testing has witnessed a string of institutional investors and corporations, who are looking at the growing demand for liquid biopsy tests and are investing in the industry be it small or large investments. Big companies are acquiring/partnering with smaller companies or start-ups to increase their market share. Some of the prominent mergers and acquisitions/partnerships in the smart home ecosystem include:

·         In 2020, Roche acquired a POC glucose testing company called mySugr, which provides mobile apps and digital services to people with diabetes. Roche also introduced its Accu-Chek Guide system, a POC testing device that allows for easier and more accurate testing of blood glucose levels.

·         In 2020, Aboott launched FreeStyle Libre 2 system. This system allows for continuous glucose monitoring without the need for fingersticks, making it easier for people with diabetes to manage their condition.

Conclusion:

In conclusion point-of-care glucose testing is a valuable tool in the management of diabetes and other conditions that require monitoring of glucose levels. With the availability of increasingly advanced glucose meters and continuous glucose monitoring systems, healthcare providers have more options than ever for measuring and tracking glucose levels at the point of care. By providing immediate results and enabling more informed decisions about patient care, point-of-care glucose testing can help improve patient outcomes and enhance the overall quality of care. Contact Universal Data Solutions, a rapidly growing dynamic market research firm led by a core of dedicated professionals for further information. According to the Universal Data Solutions analysis, the development of advanced technologies would massively transform the global scenario of point-of-care testing and as per their “Point-of-Care Testing Market” report, the global market was valued at USD 3 billion in 2021, growing at a CAGR of 4% during the forecast period from 2022 - 2028 to reach USD XX billion by 2028.